Quintiles

Type: Company

Name: Quintiles

First reported 2 hours ago - Updated 2 hours ago - 1 reports

Sun shines on Green Park Summer Fete

Hundreds of workers left their desks to enjoy lunchtime in the sun at Green Park.Many took advantage of the new deckchairs, giant bean bags and picnic rugs which are now available to the park’s employees.Others enjoyed splashing around in Longwater Lake ... [Published Wokingham Times - 2 hours ago]

Entities: Oxford Properties, Thames Water Utilities Ltd, Quintiles

First reported 19 hours ago - Updated 19 hours ago - 1 reports

Central Directorate of Interior Intelligence

Quintiles, DCRI shine in CRO industry survey

Quintiles and the Duke Clinical Research Institute are very different providers of clinical trial services but pharma executives give both high marks. Learn what makes them stand out. ... [Published Local Tech Wire - 19 hours ago]

Entities: Quintiles, Central Directorate of Interior Intelligence, Clinical trials

First reported May 21 2013 - Updated May 22 2013 - 4 reports

Quintiles Recieves Phase II/III Clinical Research Industry Accolade

Biopharma recognizes Quintiles as the leader in customer loyalty among large Clinical Research Organizations (CROs) in quality benchmarking report. ... [Published Technology Networks - May 22 2013]

Entities: Quintiles, Phase II/III, Benchmarking

First reported May 22 2013 - Updated May 22 2013 - 1 reports

Quintiles rated as leader among CROs in service quality of phase II/III studies

Quintiles is the industry leader that best differentiates itself on service quality in phase II/III clinical research, according to 157 pharmaceutical and biotechnology professionals who responded to Industry Standard Research’s (ISR).Respondents also ... [Published PharmaBiz - May 22 2013]

Entities: Quintiles, Paula Brown, Benchmarking, Life Cycle

First reported May 21 2013 - Updated May 22 2013 - 1 reports

King Pharmaceuticals Inc

Oxygen Biotherapeutics Names Col. Charles L. Pamplin III, M.D., Chief Medical Officer

- Expertise in the development of numerous commercialized drugs and his military background to support Company’s development path -MORRISVILLE, N.C.--(BUSINESS WIRE ?At this stage, the board felt it is was important to elevate the medical and product ... [Published EON - May 21 2013]

Entities: Oxygen Biotherapeutics Inc, King Pharmaceuticals Inc, Internal Medicine, Clinical Pharmacology

First reported May 21 2013 - Updated May 22 2013 - 1 reports

Quintiles als Branchenführer und Unternehmen mit höchster Servicequalität bei klinischen Studien der Phase II/III eingestuft

Biopharmabranche: In einem Leistungsvergleichsbericht unter großen klinischen Auftragsforschungseinrichtungen führt Quintiles in der KundenbindungQuintiles ist der Branchenführer, der bei der Servicequalität klinischer Forschung der Phase II/III am meisten ... [Published FinanzNachrichten.de - May 21 2013]

Entities: Quintiles, Phase II/III, Customer Loyalty, Paula Brown, Benchmarking

First reported May 21 2013 - Updated May 21 2013 - 1 reports

Quintiles may look at takeovers and strategic deals

The US contract research organization (CRO) Quintiles may look at acquisitions and more ‘strategic partnerships’ after securing a $2.43bn credit facility.The firm announced the move, which includes a $225m credit facility and a $2.2bn loan due in 2018, ... [Published Outsourcing Pharma - May 21 2013]

Entities: Quintiles, Takeover, Acquisition

First reported May 20 2013 - Updated May 20 2013 - 1 reports

After successful IPO, Quintiles plots 400 job cuts

Free Weekly CRO Newsletter Want top clinical outsourcing news headlines sent straight to your inbox? Join thousands of your biopharma colleagues who subscribe to FierceCRO for FREE! ... [Published FiercePharma - May 20 2013]

Entities: Quintiles, IPOs, Layoffs

First reported May 17 2013 - Updated May 18 2013 - 2 reports

Financings Of The Fortnight: Bluebird IPO Could Provide Validation For Gene Therapy As A Modality

During a year in which biotech IPOs have taken off, the bluebird bio issue calls for special attention. Plus news on recent financings by Quintiles, Portola, Isis and Lumena. ... [Published The Rose Sheet - May 17 2013]

Entities: Gene Therapy, IPOs, modality

First reported May 16 2013 - Updated May 17 2013 - 2 reports

Innovative Clinical Development Partnership Announced By Quintiles and Merck Serono

Agreement creates unique strategic collaboration for development and clinical trial execution ... [Published Pharmaceutical Manufacturing Magazine - May 16 2013]

Entities: Merck Serono, Quintiles, Clinical trials

First reported May 16 2013 - Updated May 16 2013 - 3 reports

Merck KGaA forges clinical alliance with Quintiles

CRO becomes sole outsourcing partner for pharma companyFresh from its successful public offering, Quintiles has now signed a strategic-level deal with Merck KGaA that is being billed as a unique alliance.The five-year deal will see Quintiles become part ... [Published PMLive - May 16 2013]

Entities: Quintiles, Merck KGaA, Merck Serono, Research & Development

First reported May 16 2013 - Updated May 16 2013 - 2 reports

Quintiles inks five-year clinical development partnership with Merck Serono

Fresh from returning to public ownership with a US$947 million offering, Quintiles has made a significant addition to its roster of strategic alliances in the form of a five-year with Merck Serono. In fact, the agreement involves a level of co-operation ... [Published Pharma Times - May 16 2013]

Entities: Merck Serono, Quintiles, Annalisa Jenkins, Patient, Immunology

Quotes

"The biggest takeaway for me is the idea that it truly is up to us – each and every individual in the Triangle - to not only have a vision for how we want our communities to grow and change, but more importantly to bravely take action to do something about it"

Four CBC'ers Become Goodmon Fellows After Leadership Triangle Regional Class [Published Capitol Broadcasting Company - 4 hours ago]

...Erfolgschancen in jeder Phase ihrer Produktlebenszyklen zu erhöhen", sagte Paula Brown Stafford, Präsidentin für Clinical Development bei Quintiles. "Wir freuen uns sehr, zu sehen, dass unsere führende Rolle und unser Einsatz sowohl für Qualität als auch für Kundenzufriedenheit von der Branche anerkannt werden."

Quintiles als Branchenführer und Unternehmen mit höchster Servicequalität bei klinischen Studien ... [Published FinanzNachrichten.de - May 21 2013]

"At this stage, the board felt it is was important to elevate the medical and product development expertise of the company as we push through our Phase IIb clinical trials and gather the data necessary to answer the FDA questions regarding Oxycyte" said Michael Jebsen, Interim CEO and Chief Financial Officer. "We believe Dr...

Oxygen Biotherapeutics Names Col. Charles L. Pamplin III, M.D., Chief Medical Officer [Published Business Wire - May 21 2013]

More From BioPortfolio on "Quintiles Rated Industry Leader and Highest in Service Quality in Phase II III Clinical Research"

Quintiles Rated Industry Leader and Highest in Service Quality in Phase II/III Clinical Research [Published BioPortfolio - May 21 2013]

More Content

sort by: Date \| Relevance
Sun shines on Green Park Summer Fete [Published Wokingham Times - 2 hours ago]
Four CBC'ers Become Goodmon Fellows After Leade... [Published Capitol Broadcasting Company - 4 hours ago]
Quintiles, DCRI shine in CRO industry survey [Published Local Tech Wire - 19 hours ago]
From The Top Line To The Bottom Line, U.S. Mult... [Published Seeking Alpha - May 22 2013]
Quintiles Recieves Phase II/III Clinical Resear... [Published Technology Networks - May 22 2013]
昆泰因其在II/III期临床研究中的顶尖服务质量被公认为业内领袖 [Published Business Wire Technology News - May 22 2013]
昆泰因其在II/III期临床研究中的顶尖服务质量被公认为业内领袖 [Published Business Wire Health News - May 22 2013]
Quintiles rated as leader among CROs in service... [Published PharmaBiz - May 22 2013]
Quintiles Rated Industry Leader and Highest in ... [Published IT News Online - May 22 2013]
Cell Therapeutics, Inc. Presents at UBS Global ... [Published Seeking Alpha - May 22 2013]
Quintiles classé leader du secteur et meilleur ... [Published Business Wire Technology News - May 21 2013]
Quintiles classé leader du secteur et meilleur ... [Published Business Wire Health News - May 21 2013]
Quintiles avaliada como empresa líder no setor ... [Published Business Wire Technology News - May 21 2013]
Quintiles avaliada como empresa líder no setor ... [Published Business Wire Health News - May 21 2013]
Quintiles als Branchenführer und Unternehmen mi... [Published FinanzNachrichten.de - May 21 2013]
Quintiles als Branchenführer und Unternehmen mi... [Published Business Wire Technology News - May 21 2013]
Quintiles als Branchenführer und Unternehmen mi... [Published Business Wire Health News - May 21 2013]
Quintiles obtuvo la calificación de líder en la... [Published Business Wire Technology News - May 21 2013]
Quintiles obtuvo la calificación de líder en la... [Published Business Wire Health News - May 21 2013]
Quintiles, Inc. (QTRN) Rated Industry Leader an... [Published BioSpace - May 21 2013]
PRA mulls initial public offering [Published Pharma Times - May 21 2013]
Samenvatting: Quintiles sectorleider en aan kop... [Published Business Wire Technology News - May 21 2013]
Samenvatting: Quintiles sectorleider en aan kop... [Published Business Wire Health News - May 21 2013]
Riassunto: Quintiles riconosciuta come leader d... [Published Business Wire Technology News - May 21 2013]
Riassunto: Quintiles riconosciuta come leader d... [Published Business Wire Health News - May 21 2013]
Oxygen Biotherapeutics Names Col. Charles L. Pa... [Published EON - May 21 2013]
Quintiles may look at takeovers and strategic d... [Published Outsourcing Pharma - May 21 2013]
Oxygen Biotherapeutics Names Col. Charles L. Pa... [Published Business Wire - May 21 2013]
Quintiles Rated Industry Leader and Highest in ... [Published BioPortfolio - May 21 2013]
Quintiles Rated Industry Leader and Highest in ... [Published Business Wire Technology News - May 21 2013]

sort by: Date \| Relevance
Ten Hot Stories: LPs Talk Tough to VCs, ‘First ... [Published PE Hub Blog - May 17 2013] Time to catch up on some hot stories you may have missed this week. Here are the 10 most popular posts on peHUB based on number of unique pageviews from our regular readers for May 13 – 17. 1. LPs to VCs: Cut Fund Size, Show Us the Money and Stop ...
Deals Of The Week Is Keeping Score – Valeant Wa... [Published The IN VIVO Blog - May 17 2013] Whether the pastime is baseball, Broadway or the daytime soaps, the old adage is that you can’t keep track of the players without a scorecard. The M&A front involving specialty pharma and generic drug makers has become similarly frenzied, as Canada’s ...
Financings of the Fortnight Waits For Public In... [Published The IN VIVO Blog - May 17 2013] It’s been another IPO-intensive couple of weeks here at FOTF HQ. We keep looking for other things to write about, but sometimes the fastest shave on deadline is with Occam’s razor. Or something like that. We didn't exactly ace our philosophy classes ...
Merck Serono, Quintiles sign five-year clinical... [Published PBR - News - May 16 2013] Merck Serono and Quintiles have entered into a five-year clinical development agreement for the development and clinical trial execution. ...
TPG Scores Big Windfall with Quintiles, Norther... [Published PE Hub Blog - May 14 2013] TPG has had much luck tapping the IPO market during the past 12 months. The PE firm’s most recent success was the public offering of Quintiles Transnational Holdings last week. TPG’s investment in Quintiles dates back to 2003 when the PE firm, ...